SCHEMBL6796069

SCHEMBL6796069

CC(=O)N(C(C)=O)c1ccncc1C(N)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
KDM4E B2RXH2 3/20 0.41
HTT P42858 1/20 0.41
GAA P10253 2/20 0.40
ADORA3 P0DMS8 1/20 0.40
TSHR P16473 1/20 0.40
MC4R P32245 1/20 0.40
ADRA1A P35348 1/20 0.40
MC3R P41968 1/20 0.40
F7 P08709 1/20 0.39
F3 P13726 1/20 0.39
SARM1 Q6SZW1 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
SIRT6 Q8N6T7 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
SIRT5 Q9NXA8 1/20 0.39
SIRT4 Q9Y6E7 1/20 0.39
MKNK1 Q9BUB5 4/20 0.39
MKNK2 Q9HBH9 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2770960 0.81 SIRT3 (0.61) SIRT3TDP1KDM4EHTTGAA
SCHEMBL27514150 0.76 GAA (0.53) KDM4EHTTGAATSHRSIRT2
SCHEMBL1330970 0.74 TDP1 (0.67) SIRT3TDP1KDM4EHTTGAA
SCHEMBL1687197 0.74 TDP1 (0.67) SIRT3TDP1KDM4EHTTGAA
SCHEMBL1265706 0.73 SIRT3 (1.00) SIRT3TDP1KDM4EHTTGAA
SCHEMBL29682389 0.73 SIRT3 (1.00) SIRT3TDP1KDM4EHTTGAA
SCHEMBL29741235 0.73 TDP1 (0.59) SIRT3TDP1KDM4EHTTGAA
SCHEMBL4306411 0.73 TDP1 (0.55) SIRT3TDP1KDM4EHTTGAA
SCHEMBL29740415 0.73 TDP1 (0.59) SIRT3TDP1KDM4EHTTGAA
Acetone SCHEMBL5667714 0.71 SIRT3 (0.58) SIRT3TDP1KDM4EHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6743794-B2 MULTIDRUG RESISTANCE PROTEIN; CANCER; 3-(9-CHLORO-3-METHYL-4-OXO-5H-ISOXAZOLO(4,3-C)QUINOLIN-5-YL)) CYCLOHEXYL)-2-PIPERIDYLACETAMIDE ELI LILLY AND COMPANY 2004-06-01 US disclosed